-
1
-
-
59349092083
-
" Clinical Trials in Stem Cell Transplantation: Guidelines for Scientific and Ethical Review,"
-
B. Lo, " Case-Based Reasoning in Stem Cell Clinical Trials: The Case of Parkinson Disease," 38, no. 2 (2010); D. Magnus, " Translating Stem Cell Research: Challenges at the Research Frontier," 38, no. 2 (2010)
-
Lo B, Kriegstein A, Grady D. " Clinical Trials in Stem Cell Transplantation: Guidelines for Scientific and Ethical Review," Clinical Trials 2008, 5(no. 5):517-522. B. Lo, " Case-Based Reasoning in Stem Cell Clinical Trials: The Case of Parkinson Disease," 38, no. 2 (2010); D. Magnus, " Translating Stem Cell Research: Challenges at the Research Frontier," 38, no. 2 (2010)
-
(2008)
Clinical Trials
, vol.5
, Issue.5
, pp. 517-522
-
-
Lo, B.1
Kriegstein, A.2
Grady, D.3
-
2
-
-
20544446193
-
-
National Academy of Sciences, Washington, D.C., National Academies Press
-
Guidelines for Human Embryonic Stem Cell Research 2005, National Academy of Sciences, Washington, D.C., National Academies Press
-
(2005)
Guidelines for Human Embryonic Stem Cell Research
-
-
-
5
-
-
34247632610
-
Guidelines for the Conduct of Human Embryonic Stem Cell Research
-
International Society for Stem Cell Research, , last visited April 7, 2010
-
Guidelines for the Conduct of Human Embryonic Stem Cell Research. 2006, http://www.isscr.org/guidelines/ISS-CRhESCguidelines2006.pdf, International Society for Stem Cell Research, , last visited April 7, 2010
-
(2006)
-
-
-
6
-
-
34247632610
-
" Guidelines for the Conduct of Human Embryonic Stem Cell Research,"
-
See, International Society for Stem Cell Research, , last visited April 7, 2010
-
" Guidelines for the Conduct of Human Embryonic Stem Cell Research," http://www.isscr.org/guidelines/index.htm, See, International Society for Stem Cell Research, , last visited April 7, 2010
-
-
-
-
7
-
-
70449521274
-
Guidelines for the Clinical Translation of Stem Cells
-
International Society for Stem Cell Research, , last visited April 7, 2010
-
Guidelines for the Clinical Translation of Stem Cells. 2008, http://www.isscr.org/clinical_trans/pdfs/ISSCRGLClinicalTrans.pdf, International Society for Stem Cell Research, , last visited April 7, 2010
-
(2008)
-
-
-
8
-
-
56749173982
-
" New ISSCR Guidelines Underscore Major Principles for Responsible Translational Stem Cell Research,"
-
Hyun I, Lindvall O, Ahrlund-Richter L, Cattaneo E, Cavazzana-Calvo M, Cossu G, De Luca M, Fox I J, Gerstle C, Goldstein RA, Hermeren G, High K A, Kim H O, Lee HP, Levy-Lahad E, Li L, Lo B, Marshak D R, McNab A, Munsie M, Nakauchi H, Rao M, Rooke H M, Valles C S, Srivastava A, Sugarman J, Taylor P L, Veiga A, Wong A L, Zoloth L, Daley G Q. " New ISSCR Guidelines Underscore Major Principles for Responsible Translational Stem Cell Research," Cell Stem Cell 2008, 3(no. 6):607-609.
-
(2008)
Cell Stem Cell
, vol.3
, Issue.6
, pp. 607-609
-
-
Hyun, I.1
Lindvall, O.2
Ahrlund-Richter, L.3
Cattaneo, E.4
Cavazzana-Calvo, M.5
Cossu, G.6
De Luca, M.7
Fox, I.J.8
Gerstle, C.9
Goldstein, R.A.10
Hermeren, G.11
High, K.A.12
Kim, H.O.13
Lee, H.P.14
Levy-Lahad, E.15
Li, L.16
Lo, B.17
Marshak, D.R.18
McNab, A.19
Munsie, M.20
Nakauchi, H.21
Rao, M.22
Rooke, H.M.23
Valles, C.S.24
Srivastava, A.25
Sugarman, J.26
Taylor, P.L.27
Veiga, A.28
Wong, A.L.29
Zoloth, L.30
Daley, G.Q.31
more..
-
9
-
-
77954907943
-
-
See Lo et al., note 1.
-
See Lo et al., note 1.
-
-
-
-
10
-
-
50549094908
-
" Cell-Based Interventions for Neurologic Conditions: Ethical Challenges for Early Human Trials,"
-
Mathews D J, Sugarman J, Bok H, Blass D M, Coyle J T, Duggan P, Finkle J, Greely H T, Hillis A, Hoke A, Johnson R, Johnston M, Kahn J, Kerr D, Kurtzberg J, Liao S M, McDonald J W, McKhann G, Nelson K B, Rao M, Regenberg A, Siegel A W, Smith K, Solter D, Song H, Vescovi A, Young W, Gearhart J D, Faden R. " Cell-Based Interventions for Neurologic Conditions: Ethical Challenges for Early Human Trials," Neurology 2008, 71(no. 4):1-6.
-
(2008)
Neurology
, vol.71
, Issue.4
, pp. 1-6
-
-
Mathews, D.J.1
Sugarman, J.2
Bok, H.3
Blass, D.M.4
Coyle, J.T.5
Duggan, P.6
Finkle, J.7
Greely, H.T.8
Hillis, A.9
Hoke, A.10
Johnson, R.11
Johnston, M.12
Kahn, J.13
Kerr, D.14
Kurtzberg, J.15
Liao, S.M.16
McDonald, J.W.17
McKhann, G.18
Nelson, K.B.19
Rao, M.20
Regenberg, A.21
Siegel, A.W.22
Smith, K.23
Solter, D.24
Song, H.25
Vescovi, A.26
Young, W.27
Gearhart, J.D.28
Faden, R.29
more..
-
11
-
-
33747961811
-
" Empirical Research on Informed Consent,"
-
Sugarman J, McCrory D C, Powell D, Krasny A, Adams B, Ball E, Cassell C. " Empirical Research on Informed Consent," Hastings Center Report 1999, 29(no. 1):S1-S42.
-
(1999)
Hastings Center Report
, vol.29
, Issue.1
-
-
Sugarman, J.1
McCrory, D.C.2
Powell, D.3
Krasny, A.4
Adams, B.5
Ball, E.6
Cassell, C.7
-
12
-
-
84865921861
-
" What Patients Say About Medical Research,"
-
Sugarman J, Kass N E, Goodman S N, Perentesis P, Fernandes P, Faden R R. " What Patients Say About Medical Research," IRB 1998, 20(no. 4):1-7.
-
(1998)
IRB
, vol.20
, Issue.4
, pp. 1-7
-
-
Sugarman, J.1
Kass, N.E.2
Goodman, S.N.3
Perentesis, P.4
Fernandes, P.5
Faden, R.R.6
-
13
-
-
0032908728
-
" Rewriting the 'Points to Consider': The Ethical Impact of Guidance Document Language,"
-
King N M P. " Rewriting the 'Points to Consider': The Ethical Impact of Guidance Document Language," Human Gene Therapy 1999, 10(no. 1):133-139.
-
(1999)
Human Gene Therapy
, vol.10
, Issue.1
, pp. 133-139
-
-
King, N.M.P.1
-
14
-
-
14744283614
-
" Evaluating the Quality of Informed Consent,"
-
Sugarman J, Lavori P W, Boeger M, Cain C, Edson R, Morrison V, Yeh S S. " Evaluating the Quality of Informed Consent," Clinical Trials 2005, 2(no. 1):1-8.
-
(2005)
Clinical Trials
, vol.2
, Issue.1
, pp. 1-8
-
-
Sugarman, J.1
Lavori, P.W.2
Boeger, M.3
Cain, C.4
Edson, R.5
Morrison, V.6
Yeh, S.S.7
-
15
-
-
54549084479
-
" Enhancing Communication Among Data Monitoring Committees and Institutional Review Boards,"
-
Taylor H A, Chaisson L, Sugarman J. " Enhancing Communication Among Data Monitoring Committees and Institutional Review Boards," Clinical Trials 2008, 5(no. 3):277-282.
-
(2008)
Clinical Trials
, vol.5
, Issue.3
, pp. 277-282
-
-
Taylor, H.A.1
Chaisson, L.2
Sugarman, J.3
-
16
-
-
33845984954
-
" Establishing Procedures for Institutional Oversight of Stem Cell Research,"
-
J. Sugarman and A. Siegel, " How to Determine Whether Existing Human Embryonic Stem Cell Lines Can Be Used Ethically," 3, no. 3 (2008): 238-239; J. Sugarman and A. W. Siegel, " When Embryonic Stem Cell Lines Fail to Meet Consent Standards," 322, no. 5900 (2008): 379.
-
Zettler P, Wolf L, Lo B. " Establishing Procedures for Institutional Oversight of Stem Cell Research," Academic Medicine 2007, 82(no. 1):6-10. J. Sugarman and A. Siegel, " How to Determine Whether Existing Human Embryonic Stem Cell Lines Can Be Used Ethically," 3, no. 3 (2008): 238-239; J. Sugarman and A. W. Siegel, " When Embryonic Stem Cell Lines Fail to Meet Consent Standards," 322, no. 5900 (2008): 379.
-
(2007)
Academic Medicine
, vol.82
, Issue.1
, pp. 6-10
-
-
Zettler, P.1
Wolf, L.2
Lo, B.3
-
17
-
-
0742266629
-
" 'Special Scrutiny': A Targeted Form of Research Protocol Review,"
-
on behalf of the Consortium to Examine Clinical Research Ethics
-
Levine C, Faden R, Grady C, Hammerschmidt D, Eckenwiler L, Sugarman J. " 'Special Scrutiny': A Targeted Form of Research Protocol Review," Annals of Internal Medicine 2004, 140(no. 3):220-223. on behalf of the Consortium to Examine Clinical Research Ethics
-
(2004)
Annals of Internal Medicine
, vol.140
, Issue.3
, pp. 220-223
-
-
Levine, C.1
Faden, R.2
Grady, C.3
Hammerschmidt, D.4
Eckenwiler, L.5
Sugarman, J.6
-
18
-
-
77954904093
-
-
See Lo, et al. note 1.
-
See Lo, et al. note 1.
-
-
-
-
19
-
-
84855634795
-
-
Office of Biological Activities, National Institutes of Health. Appendix L, , last visited April 7, 2010
-
http://oba.od.nih.gov/oba/rac/guidelines_02/Appendix_L.htm, Office of Biological Activities, National Institutes of Health. Appendix L, , last visited April 7, 2010
-
-
-
-
20
-
-
0032873764
-
-
National Institutes of Health (NIH), Gene Therapy Policy Conference: Prenatal Gene Transfer: Scientific, Medical, and Ethical Issues, January 7-8, 1999,, last visited April 7, 2010); J. Sugarman, " Ethical Considerations in Leaping from Bench to Bedside," 285, no. 5436 (1999): 2071-2072
-
http://oba.od.nih.gov/oba/rac/gtpcconc.pdf, National Institutes of Health (NIH), Gene Therapy Policy Conference: Prenatal Gene Transfer: Scientific, Medical, and Ethical Issues, January 7-8, 1999,, last visited April 7, 2010); J. Sugarman, " Ethical Considerations in Leaping from Bench to Bedside," 285, no. 5436 (1999): 2071-2072
-
-
-
-
21
-
-
84855617832
-
RAC Statement
-
Recombinant DNA Advisory Committee, , last visited April 7, 2010 M 11
-
RAC Statement. March 11, 1999, http://oba.od.nih.gov/oba/rac/racinutero.pdf, Recombinant DNA Advisory Committee, , last visited April 7, 2010
-
(1999)
-
-
-
22
-
-
56549103448
-
" Stem Cell Clinics Online: The Direct-to-Consumer Portrayal of Stem Cell Medicine,"
-
S. Kiatpongsan and D. Sipp, " Monitoring and Regulating Offshore Stem Cell Clinics," 323, no. 5921 (2009): 1564-1565.
-
Lau D, Ogbogu U, Taylor B, Stafinski T, Menon D, Caulfield T. " Stem Cell Clinics Online: The Direct-to-Consumer Portrayal of Stem Cell Medicine," Cell Stem Cell 2008, 3(no. 6):591-594. S. Kiatpongsan and D. Sipp, " Monitoring and Regulating Offshore Stem Cell Clinics," 323, no. 5921 (2009): 1564-1565.
-
(2008)
Cell Stem Cell
, vol.3
, Issue.6
, pp. 591-594
-
-
Lau, D.1
Ogbogu, U.2
Taylor, B.3
Stafinski, T.4
Menon, D.5
Caulfield, T.6
-
23
-
-
77954901262
-
-
See ISSCR, note 7.
-
See ISSCR, note 7.
-
-
-
-
24
-
-
77954921502
-
-
see Lo, et al., note 1
-
see Lo, et al., note 1
-
-
-
|